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Abstract
Background: In this paper, the authors present a criti-
cal review of different studies regarding hair testing of 
endogenous γ-hydroxybutyrate (GHB), concentrations in 
chronic users, and values measured after a single GHB 
exposure in drug facilitated sexual assault (DFSA) cases 
together with the role of a recently identified GHB metabo-
lite, GHB-glucuronide.
Content: The following databases (up to March 2017) 
PubMed, Scopus and Web of Science were used, search-
ing the following key words: γ-hydroxybutyrate, GHB, 
GHB glucuronide, hair. The main key words “GHB” and 
“γ-hydroxybutyrate” were searched singularly and then 
associated individually to each of the other keywords.
Summary: Of the 2304  sources found, only 20  were 
considered appropriate for the purpose of this paper. 
Summing up all the studies investigating endogenous 
GHB concentration in hair, a very broad concentration 
range from 0 to 12 ng/mg was found. In order to detect a 
single GHB dose in hair it is necessary to commonly wait 
1 month for collecting hair and a segmental analysis of 3 
or 5 mm fragments and the calculation of a ratio between 
the targeted segment and the others represent a reliable 
method to detect a single GHB intake considering that the 
ratios presently proposed vary from 3 and 10. The only two 
studies so far performed, investigating GHB-Glucuronide 
in hair, show that the latter does not seem to provide any 
diagnostic information regarding GHB exposure.
Outlook: A practical operative protocol is proposed to be 
applied in all suspected cases of GHB-facilitated sexual 
assault (GHB-FSA).
Keywords: drug facilitated sexual assault (DFSA), foren-
sic toxicology; GHB-glucuronide; hair; γ-hydroxybutyrate 
(GHB).
Introduction
The use of hair as an alternative and/or complementary 
matrix has increased in toxicological investigations with 
several clinical and forensic applications including: work-
place drug testing, drug treatment programs, drug-facili-
tated sexual assault (DFSA), drug compliance testing and 
drug abstinence monitoring, long-term drug exposure in 
living and in post-mortem cases. Hair is a particular matrix 
as no active drug metabolism or excretion occurs within 
its structure once drugs have been deposited, unless cos-
metic treatments can partially degrade the incorporated 
drugs [1, 2].
This is not the only issue to be evaluated when inter-
preting hair analysis, but also the risk of passive exposure/
contamination for the external presence of drugs in hair or 
the presence of endogenous compounds, which can also 
be exogenously administrated. In this latter case the sole 
presence of the substance in hair is insufficient to confirm 
exogenous administration [3, 4].
An important example of this latter occurrence is that 
of γ-hydroxybutyrate (GHB). GHB has a dual nature, endog-
enous and exogenous, which makes the proof of its eventual 
exogenous intake a complicated task. Indeed, trace amounts 
of GHB are produced in various tissues, including the brain, 
where it functions as both a precursor and a metabolite of 
the major inhibitory neurotransmitter γ-aminobutyric acid 
(GABA) [5]. On the other hand, GHB finds a broad applica-
tion not only as a recreational drug of abuse in different 
contexts and in DFSA cases but also as a therapeutic agent 
under the form of sodium oxybate for the treatment of nar-
colepsy, the treatment of alcohol withdrawal syndrome and 
the maintenance of alcohol abstinence [6].
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The aim of this paper was to provide a critical review 
of the literature to compare the results obtained in dif-
ferent studies regarding GHB endogenous levels in hair, 
taking into account the role of hair color, possible cos-
metic treatment, age, gender and eventual pathologies 
which can interfere with GHB values in hair. The authors 
also focused on hair analysis in GHB chronic users, on 
analytical approaches adopted for the detection of single 
GHB doses in hair especially in DFSA cases and on the role 
of recently identified new metabolites of GHB, in particu-
lar GHB-glucuronide.
Lastly, an overview of analytical methods for the 
determination of GHB in hair together with the extraction 
techniques used and the possible applications of these 
methods was provided.
After examining all these aspects, the authors drew 
exhaustive conclusions and provided possible future per-
spectives in the toxicological investigation of GHB in hair. 
A practical protocol to be applied in suspected cases of 
GHB-FSA has been also proposed.
Materials and methods
The following databases (up to March 2017) PubMed, 
Scopus and Web of Science were used, searching the 
following key words: γ-hydroxybutyrate, GHB, GHB-
glucuronide, hair. The main key words “GHB” and 
“γ-hydroxybutyrate” were searched singularly and then 
associated individually to each of the other keywords.
Of the 2304 sources found, only 20 [7–26] were consid-
ered appropriate for the purpose of this paper. A flowchart 
of the selected papers and inclusion criteria are reported 
in Figure 1.
Results
GHB endogenous levels in hair
“As GHB is endogenous, GHB may be detected in hair at 
low concentration and as such, the presence of GHB alone 
is insufficient to confirm exogenous administration”. This 
sentence has been reported in the Guidelines of Society 
of Hair Testing 2012 [27, 28]. However, no reference values 
of endogenous GHB in hair were provided in the same 
guidelines.
Literature searching has identified eight different 
studies [8, 9, 15, 16, 18, 20–22] where endogenous GHB 
values were investigated in hair. The first study by Kintz 
and collaborators in 2003, analyzed 24  hair samples 
γ-Hydroxybutyrate
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Figure 1: Flowchart of the selected papers and inclusion criteria.
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collected from 8  males and 16 females [8]. They tested 
the first proximal 3  cm (from the root) of each of the 
24  hair samples obtaining a range of values from 0.5 
to 12.0 ng/mg. Moreover, they also evaluated if hair 
color and gender could affect endogenous hair GHB 
values, but no significant differences were found among 
hair strands of various colors (black [n = 10], mean: 
2.37 ± 0.68  ng/mg; brown [n = 6], mean: 2.21 ± 0.71 ng/
mg; blond [n = 8], mean: 2.44 ± 0.39 ng/mg) or in subjects 
of different gender (males, mean: 2.21 ± 0.57; females, 
mean: 2.47 ± 0.69 ng/mg).
Similarly, in 2003, Goullè et  al. [9] measured base-
line levels of GHB in 61 drug-free donors with results in 
the range of 0.32–1.86 ng/mg. Also in this case, it was 
found that hair color did not affect GHB content (blond 
hair [n = 12], 0.60 ± 0.19 ng/mg GHB, brown hair [n = 30], 
0.90 ± 0.42 ng/mg GHB, black hair [n = 19], 0.90 ± 0.37 ng/
mg GHB). In the same study, segmental hair analysis into 
3 mm segments was performed in the other 12 volunteers 
(non-GHB consumers). In this case, a mean concentration 
of 1.22 ng/mg (range: 0.31–8.4 ng/mg) and a relative stand-
ard deviation for each individual ranging from 6.75% to 
37.98%, was detected.
After these early investigations, recently further 
studies have been published in this field. Schröck et  al. 
[15], obtained endogenous hair GHB in the range of 
0.1–1.3 ng/mg examining hair samples of 27 GHB-free sub-
jects with 8 of the 27 with concentrations below the limit 
of quantitation (LOQ) of 0.1 ng/mg hair.
In 2015, Bertol and Busardò and their respective 
research groups performed a study where hair samples 
of 30 volunteers were selected and divided accord-
ing to color (10  samples of black hair, 10  samples of 
blond hair, and 10  samples of hair dyed with different 
colors) for the determination of endogenous GHB [16]. 
GHB was detected in the range between 0 and 5.09 
ng/mg. In detail, black hair mean concentration was 
2.11 ± 1.40 ng/mg with a range from  <limit of detection 
(LOD) to 4.49 ng/mg; the blond hair mean concentration 
was 2.25 ± 1.31 ng/mg with a range from 0.58 to 5.09 ng/
mg and the dyed hair mean concentration was 2.39 ± 0.97 
ng/mg with a range from 0.61 to 4.02 ng/mg. Similarly to 
the studies of Kintz et al. [8] and Goullè et al. [9] there 
were no statistically significant differences in GHB con-
centration among the different hair colors. Moreover, no 
significant differences with respect to sex or age of the 
subjects were found.
In the same year, Bertol et  al. [16] reported that, 
due to sweat contamination, GHB concentration in the 
first 0.5  cm hair segment of a group of non-consumers 
was statistically higher in comparison to all the other 
subsequent segments where mean GHB concentration 
was 1.27 ± 0.73 ng/mg.
More recently, Vaiano and colleagues [18] published 
another study where they investigated the role of age and 
gender on GHB baseline levels in hair and for this purpose 
a large number of subjects were included (n = 150). GHB 
was detected in the range of 0.27–2.84 ng/mg (mean: 
0.71 ± 0.289 ng/mg), in accordance with previously pub-
lished range values [8, 9, 15, 16]. Moreover, the authors 
highlighted that in males hair GHB concentration was sig-
nificantly higher than in females: 0.829 vs. 0.596 ng/mg; 
p < 0.05.
This result was in contrast with their previous study, 
where it was not highlighted. Nevertheless, in this case 
a higher number of subjects was employed and the first 
cm of each hair sample was excluded to reduce the risk 
of sweat contamination as far as possible. Similarly to the 
results obtained by Vaiano et al., a significant difference 
(p < 0.001) between males and females was also detected 
by Shi et al. [20] when analyzing endogenous GHB in hair 
samples of 66 drug-free Chinese donors. The mean GHB 
value in males was 2.95 ng/mg (0.92–4.91 ng/mg, n = 35), 
whereas the mean value in females was 0.77 ng/mg (0.28–
1.95 ng/mg, n = 31).
To demonstrate that endogenous GHB values in hair 
are not affected by post mortem enzymatic processes, 
Castro et  al. [21] evaluated whole blood and hair post- 
mortem GHB values in 32 fatalities with previous infor-
mation on death and autopsy data. Post-mortem interval 
(up to 5 days between death and sampling) affected GHB 
whole blood concentrations, but not that in hair samples 
where GHB was in a range of values similar to those of 
ante-mortem cases: 0.16–3.12 ng/mg (mean: 0.92 ng/mg).
Finally, in 2016 Kintz [22] documented a case of single 
exposure to GHB with a novel approach and he also col-
lected hair samples from 12 non-consumers as a control 
group. The not decontaminated hair was cut into 6 × 1 cm 
segments. In the first cm, GHB values were in the range 
of 0.2–20 ng/mg, whereas in all the other segments it was 
always lower than 4 ng/mg.
All the above reported studies are briefly summarized 
in Table 1.
GHB long-term exposure in hair
There are few reports in the literature where chronic GHB 
exposure has been documented using hair. In 2005, a first 
French case of a fatal GHB overdose involving a 43-year-
old man was studied by Kintz et al. [10] measuring GHB 
at very high concentrations in femoral and cardiac blood, 
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urine, bile, vitreous humor, gastric content and pubic 
hair, as no head hair was available. Pubic hair was cut into 
three segments of 8 mm each and GHB was detected at the 
following concentrations: 25, 22.6 and 19.4 ng/mg, indicat-
ing a chronic GHB abuse.
In 2012 Bertol et al. [14] presented a case involving a 
40-year-old man with a long history of GHB abuse and 
abstinence in the previous 2 months due to house arrest. 
A 17 cm long hair shaft was taken from the posterior vertex 
of the head and cut into 1 cm segments for the first 3 cm 
and then into 2 cm segments for the remaining proximal 
14 cm. Ten different segments were obtained in total. The 
first three showed the following concentrations: 3.52, 1.49 
and 1.2 ng/mg, whereas in the distal seven segments, GHB 
concentration ranged from 4.74 to 10.74 ng/mg. These 
GHB values allowed the authors to confirm that during 
the period in which the subject was under house arrest he 
did not use GHB whereas previously he was a chronic con-
sumer and that the first hair segment showed higher GHB 
values for drug incorporation through sweat.
Mehling et  al. [19] reported a DFSA case involving a 
6-year-old female, who died following GHB sedation. GHB 
Table 1: Brief overview of studies focusing on endogenous GHB concentrations in hair.
Hair color Gender N GHB conc., ng/mg Further information Study/year/reference
Black, brown 
and blond
8 M + 16 F 24 0.5–12a First 3 cm Kintz et al. [8]
N.S. M 8 2.21 ± 0.57b
N.S. F 16 2.47 ± 0.69b
Black M + F 10 2.37 ± 0.68b
Brown M + F 6 2.21 ± 0.71b
Blond M + F 8 2.44 ± 0.39b
Black, brown 
and blond
M + F 61 0.32–1.86a No hair segmentation Goullè et al. [9]
Black N.S. 19 0.90 ± 0.37b
Brown N.S. 30 0.90 ± 0.42b
Blond N.S. 12 0.60 ± 0.19b
N.S. N.S. 12 1.22c
0.31–8.4a
Hair segmentation (3 mm)
N.S. N.S. 27 0.1–1.3a,e Schröck et al. [15]
N.S. N.S. 30 0.0–5.09a Hair segmentation (5 mm) Bertol et al. [16]
Black 5 M + 5 F 10 0–4.49a
2.11 ± 1.40b
Blond 5 M + 5 F 10 0.58–5.09a
2.25 ± 1.31b
Dyed F 10 0.61–4.02a
2.39 ± 0.97b
Various 
colors
6 M + 6 F 12 1.27 ± 0.73b Hair segmentation (5 mm) – 
The first 5 mm were excluded
Various 
colors
75 M + 75 F 150 0.71 ± 0.29b
0.27–2.84a
The first cm was excluded Vaiano et al. [18]
M 75 0.83 ± 0.34b
F 75 0.60 ± 0.16b
N.S. 35 M + 31 F 66 0.28–4.91a
1.93 ± 1.4b
The first 3 cm were analyzed Shi et al. [20]
N.S. M 35 0.92–4.91a
2.95c
N.S. F 31 0.28–1.95a
0.77c
N.S. 23 M + 9 F 32 0.16–3.12a
0.92d
Post-mortem cases Castro et al. [21]
N.S. N.S. 12 First cm: 0.2–20a
Other segments: <4
Hair samples were cut into 
1 cm segments. Hair samples 
were not decontaminated
Kintz [22]
aRange. bMean ± SD. cMean. dMedian. N.S., not specified. eIn eight of the 27 hair samples the GHB concentrations were below the LOQ of  
0.1 ng/mg hair.
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analysis was performed on a 16  cm hair shaft. The first 
proximal 4  cm of the hair were cut into 2  cm segments, 
whereas the next 12  cm were cut into segments of 1  cm 
length. The highest concentrations of GHB in the range 
of 13.6–40.8 ng/mg were found in the proximal seven hair 
segments and allowed to demonstrate a long exposure to 
GHB. When confronted with these results, the girl’s uncle 
admitted the chronic administration of GHB to the child in 
the previous 8 months before death.
In the case of a 69-year-old man who was discovered 
dead at a friend’s home, Jamey et al. reported a value of 
hair GHB in a 6 cm segment of 96.3 ng/mg suggesting a 
repeated consumption of this substance [23]. Toxicologi-
cal analysis in peripheral blood also revealed the presence 
of 3-mmethylmethcathinone, pseudoephedrine together 
with GHB.
GHB single dose detected in hair
The identification of GHB exposure following a single dose 
administration has always represented a very difficult 
task for all forensic toxicologists dealing with this issue. 
As GHB has a very short detection window in conventional 
biological matrices, about 4–5  h in blood and 8–10  h in 
urine, if a longer time has elapsed after its ingestion there 
is little hope of detecting measurable amounts in these 
two matrices [5, 27]. Hence, some studies have focused on 
the detection of a single GHB dose in hair, which repre-
sents a crucial point especially in DFSA and other criminal 
cases [7–9, 15, 16, 20, 22].
One of the first studies [7] published in 2001 investi-
gating GHB in hair, following a single dose administra-
tion, involved a 22-year-old female who had ingested a 
single GHB dose and died about 7 h later. Hair was plucked 
from the scalp. The root bulbs were removed, washed with 
sodium dodecyl sulfate and water and analyzed, whereas 
the hair shaft, also washed with sodium dodecyl sulfate 
and water, was cut in segments of 1.3 cm (0.5 inch). Seg-
mental hair analysis showed no detectable amounts of 
GHB (LOD = 1 ng/mg), whereas hair root bulbs showed 
the following concentrations: 47.4 ng/mg for washed and 
2221 ng/mg for unwashed hair, demonstrating that GHB is 
rapidly distributed into the hair follicle.
In a study published in 2003, Kintz et  al. sought to 
investigate GHB hair concentration after a single intake 
[8]. For this reason, they administered a 25 mg/kg single 
dose of GHB to a 41-year-old man (weight 67 kg) and had 
available a DFSA case involving a 19-year-old female who 
had drunk a soft drink spiked with the drug. In both cases 
hair was collected 1 month after the single exposure. 
Hair samples were cut into 3-mm segments over a length 
of 3 cm (10 segments). Segmental hair analysis revealed 
in both cases GHB peak values, in the fifth segment for 
the administered subject and in the fourth segment in 
the DFSA case. The GHB peak values detected in the fifth 
and fourth segments demonstrated that a single exposure 
could be detected in hair (Figure 2A and B).
Goullè et al. [9] reported a case regarding a 29-year-
old Black female raped under the influence of GHB, after 
drinking a glass of champagne. A 24-cm black hair shaft 
was collected and cut into 3-mm long segments (80 seg-
ments in total) 7 days after the rape and analyzed for 
GHB. The first three segments closer to the scalp showed 
the following GHB concentrations: 3.1, 5.3 and 4.3 ng/mg, 
whereas in the other 77 segments the mean concentration 
was 0.71 ng/mg (SD = 0.17 ng/mg). This mean value rep-
resented the baseline GHB level of the woman, whereas 
the highest GHB concentration detected in the second 
proximal segment was suggestive of an exogenous GHB 
administration even taking into account the possible con-
tamination by sweat.
In contrast to the results of these two previous studies 
[8, 9] where a single GHB dose could have be identified 
in hair, Schröck et al. [15] found no increase in hair GHB 
after administering a single dose of 1.5 mL γ-butyrolactone 
(corresponding to 2.1 g of GHB, assuming a complete con-
version). Head hair from to two volunteers was collected 
on days 9, 14, 25, and 28 for one case and on days 8, 17, 
25, 37 for the other case. In both cases, head hair were 
segmented into 7 mm fragments. In addition, beard hair 
of 1 mm length was collected every day. GHB concentra-
tions in head hair were in the range of 0.1–0.6 ng GHB 
per mg hair. In beard hair, the measured GHB concentra-
tions were up to 20 times higher than those in head hair 
falling into the range of 0.2–3.1 ng/mg and 0.7–3.5 ng/mg, 
respectively, but no increased GHB values were observed 
for the first days after the intake of GBL. The explanation 
for these variations of GHB content in beard hair, provided 
by the authors, was a possible external contamination by 
sweat.
In all the above reported cases, what allowed the 
authors to confirm the administration of a single GHB 
dose in hair was the eventual rise of GHB content in tar-
geted hair segments in comparison to the content in the 
others. However, none of these studies reported which 
had to be the degree of rise in hair concentration of GHB. 
Neither the Guidelines of Society of Hair Testing reported 
in 2012 the degree of this elevation [28]. They only stated 
that it had be “consistent with the approximate timeframe 
of the incident” in order to differentiate between endog-
enous and exogenous GHB.
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In the Guidelines for the Forensic Analysis of Drugs 
Facilitating Sexual Assault and Other Criminal Acts [29], 
the United Nations Office on Drugs and Crime (UNODC) 
recommends that “the strand of hair has to be cut in 
5–10 small segments (0.3–0.5 cm long) and each segment 
analyzed for GHB to identify if one segment has GHB con-
centration 10 times higher than the others, suggesting in 
this way possible administration of exogenous GHB”. Four 
years after the release of this document, Bertol et al. [16] 
proposed lower ratios for GHB concentration in targeted 
segment vs. the others. The authors orally administered 
to 12 subjects a single 25 mg/kg GHB dose and hair shafts 
were taken 1 month and 2 months later and cut into 0.5 cm 
segments. Two ratios were obtained: 4.45:1 (95% CI 3.52–
5.63) for GHB in the second segment in the hair samples 
collected after 1 month vs. the others and 3.35:1 (95% CI 
2.14–5.18) for the fourth segment in the hair samples col-
lected after 2 months vs. the others (Figure  2C and D), 
recommended for a positive identification of single GHB 
intake.
Indeed, Bertol et al. applied these two ratios to three 
DFSA cases, allowing the identification of a single expo-
sure in two cases (cases 1 and 2) (Figure 2E and F) whereas 
for the third case it was not possible to draw exhaustive 
conclusions [16] (Figure 2G).
The two ratios proposed by Bertol et  al. [16] were 
obtained from hair samples collected 1 and 2 months after 
a single GHB exposure, but after this time frame no infor-
mation was available about eventual GHB concentration 
detectable in hair following a single dose when a longer 
period of time elapsed from drug intake. In this regard, 
Busardò et al. [25] monitored GHB peak concentration in a 
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Figure 2: Cases of single GHB detection in hair from international literature.
In all cases (A–I) a segmental hair analysis to determine the “targeted segment” was performed.
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targeted hair segment after a single DFSA administration 
over a period of 12 months. The same authors also calcu-
lated month by month the ratios between GHB value in tar-
geted segments and that in the others for up to 12 months, 
showing a progressive decrease from 5.56 at the 1st month 
to 2.84 at the 12th month [25] (Figure 2I).
The month-by-month decrease of this ratio can be 
explained by the decay of hair GHB concentration, which 
occurred during the 12-month timeframe up to 51.6% at 
the 12th month. Moreover, differently from other drugs of 
abuse no significant GHB migration in the hair shaft was 
found.
Differently from the previous study, Shi et  al. [20] 
reported another DFSA case involving a 20-year-old 
female where a 6 cm hair sample was collected 1 month 
after the assault and segmented into 1 cm fragments. High 
GHB concentration was found in the second segment 
(4.31 ng/mg) suggesting a GHB exogenous administration. 
However, no ratio with GHB values in the other segments 
was provided, making any definitive conclusion difficult 
(Figure 2H).
Different from all the above reported studies, is the 
approach to document a single GHB dose in hair, pub-
lished by Kintz in 2016 [22], where two different cases were 
evaluated. The first was that of a subject administered a 
GHB dose of 25 mg/kg whose hair was collected 12 h after 
dosing and a 22-year-old female, a victim of a sexual 
assault, whose hair was collected 14  h after the assault. 
In both cases, hair samples were not decontaminated and 
cut into 6 × 1  cm segments. In the first cm the following 
concentrations were found: 1040 and 850 ng/mg, respec-
tively, whereas in the remaining segments GHB concentra-
tion was always lower than 20 ng/mg. The comparison of 
the GHB values detected in the first hair segment of these 
two individuals with the ones of a control group of 12 sub-
jects, in the range of 0.2–20 ng GHB per mg hair allowed 
Kintz to easily discriminate between endogenous and 
exogenous GHB. This new approach which is based on the 
analysis of proximal hair samples non decontaminated 
from eventual sweat contribution allowed Kintz to obtain 
a much better discriminating ratio which could be used 
in routine cases, considering that the risk of GHB passive 
contamination is limited because the drug is generally 
used in liquid formulation and not smoked [22].
GHB-glucuronide and other potential 
 metabolites in hair
In 2003 Petersen et al. identified a new GHB metabolite 
in urine: GHB-glucuronide (GHB-glucuronide), with the 
hypothesis of using this metabolite as a biomarker for 
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GHB intoxication, by analogy with ethyl glucuronide as a 
biomarker of ethanol consumption. However, the results 
obtained in this first study did not look promising [30]. 
Only a few reports investigating GHB-glucuronide in dif-
ferent matrices [24, 26, 31, 32], were published after this 
study, two of which focused on hair [24, 26], Wang et al. 
[24] investigated the presence of GHB-glucuronide in the 
hair of 10 control subjects (laboratory staff) and in two 
GHB abusers. In the control group, GHB-glucuronide was 
found in the range of  <LOQ (0.48 ng/mg) to 1.2 ng/mg, 
whereas in the two GHB users, GHB-glucuronide was 
only slightly elevated in 10 different 3 mm hair segments 
in one of the subjects (range 1.7–3.1 ng/mg) and below the 
LOQ in the other.
Busardò et al. [26] investigated one 10 cm head hair 
sample, from a 45-year-old man who had undergone 
sodium oxybate treatment for 6 months. After decon-
tamination, the hair sample was dried and cut into 
10  segments of 1  cm each and analyzed for GHB, GHB-
glucuronide, GBL and GABA by UHPLC-MS/MS. The latter 
two compounds were not detected, whereas GHB was 
found in the first six proximal segments at significantly 
higher concentrations compared to the ones measured in 
last four segments, GHB-glucuronide was detected in all 
segments in the range: of 0.32–0.83 ng/mg, but no signifi-
cant variation was found among the all.
In 2015 Hanisch et  al. [33] investigated sulfonated 
metabolite of GHB (GHB-SUL) in urine samples on the rea-
sonable assumption that it could be formed. The obtained 
results evidenced traces of GHB-SUL in urine, therefore 
indicating that GHB is not only glucuronidated but also 
sulfonated. To our knowledge no studies investigating 
GHB-SUL have been performed in hair so far.
Analytical methods for GHB analysis in hair
Several analytical methods have been published for GHB 
analysis in hair [7–9, 12–18, 20, 24, 26], using different 
 techniques: GC-MS [7, 14, 18], GC-MS/MS [8, 9, 13, 20], 
When a GHB-FSA case is suspected
Report, when available, the approximate interval of time
between the accident and hair sampling excluding eventual
previous exposure to GHB (besides the one for which the
analysis is required), which can affect the results of the
analysis
It is necessary to take into account the onset of clinical
symptoms, which must fit with a short duration of the
sedative effects (typically 2–3 h)
If the subject has not washed his/her hair, 2 hair samples should
be collected according to Guidelines of the Society of Hair Testing
The two hair samples should be taken from the posterior vertex 2 cm per 2 cm region of the head,
close to the scalp. An expert must professionally carry out the cut. Then, each strand should be
fixed and laid out on to a piece of dry foil with a clip. For one hair sample, strings must be placed
every 10 mm for the other one every 3 or 5 mm and then the segments separated with a cutter
The first hair sample, cut into 10 mm
segments, has not to be decontaminated
according to the procedure of Kintz [22] and
this may represent the only possible
approach based on the sweat contamination
to document a single GHB dose shortly after
the exposure
The second hair sample, cut into 3 or 5 mm
segments, has to be normally
decontaminated according the SoHT
Guidelines and then analyzed by GC-MS/MS
or LC-MS/MS. This analysis allows to
determine the endogenous GHB levels in all
segments of hair.
One month after the exposure,
another hair sample has to be
collected as above
The measurement of the hair growth during the month between
the first sampling (Time 0) and the second one to carefully
determine what should be the ‘targeted segment’
Segmental hair analysis has to be performed together with the
calculation of the ratio between the targeted segments and the
others with the exclusion of the first one
Each subject has to be used as his/her own control
Figure 3: Practical protocol to be applied in all suspected cases of GHB-FSA.
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LC-MS/MS [12, 14–17] and UHPLC-MS/MS [24, 26]. The 
majority of these methods included only quali-quantitaive 
determination of GHB. Some others detected GHB with 
other compounds, such as ethyl-glucuronide [13], GABA, 
GBL [24] and GHB-glucuronide [24, 26].
Table 2 reports a brief overview of analytical methods 
applied for qualitative and quantitative analysis of GHB 
and metabolites in hair.
Conclusions and future perspectives
This comprehensive review allowed outlining some useful 
considerations:
 – Summing up all the studies investigating endog-
enous GHB in hair [7–9, 15, 16, 20, 22] a very broad 
concentration range can be reported: 0–12 ng/mg. 
Moreover, considering the experiment carried out by 
Kintz [22] in non-decontaminated hair samples, the 
upper limit of this range reaches 20 ng/mg. There-
fore, the high variability of GHB concentration in hair 
does not allow the proposal of a reliable GHB cut-off 
which can be applied unanimously to all cases to 
significantly discriminate between endogenous and 
exogenous GHB.
 – The majority of studies have detected higher GHB 
values in the hair segment closest to the scalp, dem-
onstrating the contribution from sweat even when 
hair was correctly decontaminated. In the light of 
this occurrence, at least the first 5  mm hair shaft 
should be excluded from analysis to avoid erroneous 
conclusions.
 – All the studies investigating the detection of a sin-
gle GHB dose in hair, except the one of Kintz [22] 
where a different approach is presented, indicate 
that it is necessary to wait a reasonable length of 
time for collecting hair (from a minimum of 7 days 
up to 1  month or more). The interval of 1 month 
from the possible exposure was mainly suggested 
to collect hair and this is the interval of time we 
recommend. The segmental analysis of hair into 
3 or 5 mm segments and the calculation of a ratio 
between the targeted segment and the others repre-
sent a reliable method to detect single GHB dose in 
hair and the ratios proposed by Bertol et al. [16] for 
hair samples collected after 1 and 2 months can be 
applied in routine cases.
 – Presently, the only approach which may allow to dem-
onstrate a GHB ingestion shortly after the exposure 
is the one of Kintz [22], but it can be applied only if 
the subject has not washed his/her hair because it is 
based on the contamination property of sweat.
 – The only two studies [24, 26] so far performed, investi-
gating GHB-glucuronide in hair, highlighted that this 
metabolite does not seem to provide any diagnostic 
information regarding GHB exposure.
Finally, taking into consideration all the studies up to here 
discussed we wish to propose a practical protocol to be 
applied in all suspected cases of GHB-FSA, which is pre-
sented in Figure 3.
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